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All-Trans Retinoic Acid Antagonizes UV-Induced
VEGF Production and Angiogenesis via the Inhibition
of ERK Activation in Human Skin Keratinocytes
Mi-Sun Kim1,2,3, Yeon K. Kim1,2,3, Hee C. Eun1,2,3, Kwang H. Cho1,2,3 and Jin H. Chung1,2,3
Incident UV radiation leads to the upregulation of vascular endothelial growth factor (VEGF), a potent angiogenic
factor, in human skin. However, the molecular basis of UV-induced angiogenesis in skin remains to be elucidated.
In this study, we investigated the roles of UV exposure on cutaneous angiogenesis, its associated signaling
mechanisms, and the effect of all-trans retinoic acid (tRA) on UV-induced vascularization, and VEGF expression.
Using a human epidermal cell line, HaCaT, we found that UV induces VEGF mRNA and protein expression via the
MAPK/ERK kinase–ERK1/2 (extracellular signal-regulated kinase 1/2) pathway but not via the phosphatidylinositol
3-kinase (PI3K)/Akt pathway, and that tRA pretreatment significantly inhibits UV-induced VEGF overexpression
and ERK1/2 activation. In human skin in vivo, we confirmed that skin vascularization significantly increased after a
single exposure to UV, as was evidenced by a prominent increase in vessel size, vascular density, and in the
cutaneous area occupied by vessels, and we found that these events are associated with VEGF upregulation.
Topical pretreatment with tRA under occlusion inhibited not only UV-induced VEGF upregulation and
angiogenesis with a significant reduction of vessel density but also UV-induced ERK1/2 activation in human
skin. Collectively, our data demonstrate that tRA inhibits the UV-induced angiogenic switch via downmodulation
of ERK1/2 activation and consecutive VEGF overexpression. These findings may help us understand the molecular
mechanisms that regulate skin angiogenesis due to UV exposure, and provide evidence of the potential of tRA in
terms of preventing angiogenesis-associated skin damage following exposure to UV irradiation.
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INTRODUCTION
Human skin is exposed daily to solar UV radiation and the
epidermis is a primary target for UV radiation. Chronic
exposure of skin to UV radiation leads to photoaging and
photocarcinogenesis (Clydesdale et al., 2001; Ichihashi et al.,
2003). Recently, it was reported that a single exposure to UV
radiation may induce vascular hyperpermeability, dermal
blood vessel dilation, and lead to an imbalance between
angiogenic factors and inhibitors in human skin (Yano et al.,
2005). Angiogenesis, the process of generating new capillary
blood vessels, is accompanied with physiological and
pathological conditions of skin (Detmar, 2000; Velasco and
Lange-Asschenfeldt, 2002). However, the molecular basis
and regulation of angiogenesis-associated skin damages
induced by acute UV exposure remain unclear.
It is accepted that epidermal keratinocytes have a primary
role in the physiology and pathology of cutaneous angiogen-
esis (Malhotra et al., 1989). Moreover, epidermis-derived
vascular endothelial growth factor (VEGF) is regarded as a
potent angiogenic factor in many cutaneous diseases
(Bowden et al., 2002; Gira et al., 2004). VEGF is a
homodimeric, heparin-binding glycoprotein that also binds
to specific receptors, which are mainly expressed in
endothelial cells. Alternative splicing of the original mRNA
transcript generates at least five different VEGF isoforms
(Bates et al., 2002), the 121, 165, and 189 amino-acid
isoforms of which predominate in human keratinocytes
(Ballaun et al., 1995). The expression of VEGF in both
immortalized and cultured keratinocytes is increased by
several stimulants, for example, oxidants, TNF-a, and
keratinocyte growth factor (Frank et al., 1995; Brauchle
et al., 1996). In particular, several reports have suggested that
VEGF is induced in human keratinocytes after UV exposure
(Mildner et al., 1999; Blaudschun et al., 2000).
The retinoids consist of vitamin A (retinol), and its
naturally occurring and synthetic derivatives, many of which
are potent agents for the treatment of different skin disorders,
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such as acne, psoriasis, photoaging, and cancer (Roos et al.,
1998). They modulate cell growth and differentiation in skin
(Fisher and Voorhees, 1996), and inhibit angiogenesis,
endothelial cell migration and carcinogenesis in skin cancers
(Lingen et al., 1998; Pal et al., 2000). Moreover, recent
studies have demonstrated that retinoids inhibit basal VEGF
expression in cultured keratinocytes and human skin grafted
onto nude mice (Lachgar et al., 1999; Diaz et al., 2000).
However, the effects and molecular mechanisms underlying
the action of all-trans retinoic acid (tRA) on acute UV-
induced angiogenesis in human skin have not been studied.
In this study, we examined VEGF expression after
administering by a single dose of UV radiation to HaCaT
cells and to human skin epidermis, and sought to identify the
signaling molecules involved in UV-induced VEGF expres-
sion. In addition, we investigated the effects of tRA on VEGF
expression and cutaneous vascularity after single UV
exposure in vitro and in vivo experimental systems.
RESULTS
VEGF levels are increased by UV irradiation in keratinocytes
To investigate the effect of UV on VEGF expression in the
human keratinocyte cell line HaCaT, cells were irradiated
with 50 mJ/cm2 of UV and harvested at different times
(2–10 h) after UV irradiation. To examine UV-induced VEGF
secretion, supernatants were checked for VEGF protein at
different time points by ELISA (Figure 1a). Released VEGF
protein levels were significantly increased by approximately
3.6-fold in UV-irradiated conditioned medium versus sham-
irradiated control medium 6 hours post-UV, and this was
maintained at 8 hours post-UV. As shown in Figure 1b, a low
level of VEGF mRNA was detected in quiescent, nonirra-
diated cells and VEGF mRNA expression peaked at 4 hours
post-UV by 2.1-fold versus the sham-irradiated control cells.
The MEK–ERK1/2 pathway involves UV-induced VEGF
upregulation in keratinocytes
To determine the mechanisms underlying VEGF regulation in
response to UV exposure, we attempted to identify the
pathways involved in the regulation of VEGF expression post-
UV in HaCaT cells. Extracellular signal-regulated kinase 1/2
(ERK1/2) activation and Akt activation were observed in
previous study. We pretreated cells for 30 minutes with either
a specific MAPK/ERK kinase (MEK) inhibitor, U0126 (Favata
et al., 1998), or a specific phosphatidylinositol 3-kinase PI3K
inhibitor, wortmannin (Powis et al., 1994) prior to UV. Cells
were harvested at 2 hours post-UV. As shown in Figure 2a,
these pretreatments were found to inhibit the downstream
targets, ERK1/2 or Akt. U0126 (20 mM) blocked ERK1/2
activation, and wortmannin (50 nM) blocked Akt activation.
Wortmannin had no effect on ERK phosphorylation and
U0126 had no effect on Akt phosphorylation.
To investigate the involvements of these signaling path-
ways on UV-induced VEGF expression, we examined VEGF
expressions in the presence and absence of specific
inhibitors. VEGF levels secreted from cells pretreated with/
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Figure 1. UV induced VEGF expression in HaCaT cells. Cells were seeded
at 5105 cells/well on 60-mm-well plate and starved for 24 hours before
UV irradiation (50 mJ/cm2). (a) VEGF levels were analyzed using sandwich
ELISA specific for human VEGF in the supernatants of UV-irradiated or
sham-irradiated HaCaT cells at various time points. Data are presented as
mean7SEM of four independent experiments. *Po0.05 versus nonirradiated
cells (Mann–Whitney U-test). (b) VEGF mRNA expression was analyzed by
semiquantitative RT-PCR at 4 hours post-UV. VEGF products of 516 bp, 648
and 730 bp for VEGF121, VEGF165, and VEGF189, respectively, were obtained.
(c) Desitometry was used to analyze the bands generated from VEGF and
GAPDH in five independent experiments. *Po0.05 versus nonirradiated cells
(Mann–Whitney U-test).
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Figure 2. The MEK–ERK1/2 pathway involves UV-induced VEGF
upregulation in HaCaT cells. (a) HaCaT cells were pretreated for 30 minutes
with Vehicle (DMSO), 20mM U0126, or 50 nM wortmannin before UV
irradiation. The activations of ERK1/2 and Akt were detected by Western
blotting at 2 hours post-UV. Similar results were obtained for three
independent experiments. (b) At 6 hours post-UV, VEGF levels were analyzed
by ELISA in supernatants of UV-irradiated (50 mJ/cm2) or sham-irradiated cells
in the absence or presence of inhibitors. The data shown represent the
means7SEM of four independent experiments. *Po0.05 versus nonirradiated
cells in each condition, and wPo0.05 versus vehicle pretreated UV-irradiated
cells (Mann–Whitney U-test). (c) At 4 hours post-UV, the effects of inhibitors
on VEGF mRNA expression were examined by semiquantitative RT-PCR.
Similar results were obtained for three independent experiments.
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without U0126 or wortmannin for 30 minutes prior to UV
irradiation were analyzed by ELISA. The amounts of VEGF
released into culture media 6 hours post-UV from cells was
almost 3.8-fold increase compared with cells not exposed to
UV. This UV-induced VEGF release was significantly
inhibited by U0126 (81% inhibition), but not by wortmannin
(Figure 2b). The effect of ERK inhibition on VEGF mRNA
expressions was similar to that of protein expression at
4 hours post-UV (Figure 2c). U0126 completely inhibited UV-
induced VEGF mRNA expression to the basal mRNA level,
whereas wortmannin had no inhibitory effect on UV-induced
VEGF upregulation. These findings demonstrate that the
MEK–ERK pathway positively modulates VEGF expression in
UV-irradiated keratinocytes.
tRA inhibits UV-induced VEGF expression and ERK1/2
activation in keratinocytes
We next investigated the effects of tRA on UV-induced VEGF
release and ERK activation. HaCaT cells were treated with
vehicle (0.005% DMSO) or tRA (109 M) for 24 hours prior to
UV exposure (50 mJ/cm2), and VEGF levels in supernatant
were measured by ELISA 6 hours post-UV (Figure 3a). Basal
VEGF secretion was reduced by 44.1% by tRA in nonirra-
diated cells and tRA completely blocked UV-induced VEGF
release. We next examined the effect of tRA on UV-induced
ERK1/2 phosphorylation. Cells were treated with vehicle or
tRA (109 M) for 24 hours prior to UV exposure (50 mJ/cm2),
and harvested at 2 hours post-UV (Figure 3b). Pretreatment
with tRA obviously inhibited ERK1/2 activation, in nonirra-
diated cells and irradiated cells. These data indicate tRA can
inhibit UV-induced activation of ERK1/2 protein following
VEGF upregulation in human keratinocytes.
Dermal angiogenesis is induced by a single dose of UV
irradiation in human skin in vivo
To observe the effects of UV irradiation on angiogenesis and
VEGF expression in human skin in vivo, sun-protected
buttock skin (n¼ 3) was exposed to a single dose of UV
radiation (2 MED). Skin samples were obtained after 1, 2, and
3 days. Routine haematoxylin and eosin staining revealed
obvious epidermal hyperplasia and an increased epidermal
thickness after UV exposure. Moreover, inflammatory cell
recruitment was observed in the upper dermis as compared
with normal nonirradiated skin (Figure 4a).
Immunohistochemistry for endothelial cell adhesion mo-
lecule CD31 (PECAM-1) revealed a progressive increase in
the number of enlarged vessels in UV-irradiated skin
compared with untreated control skin (Figure 4b). Compu-
ter-assisted quantitative image analysis of CD31-stained
cutaneous vessels was performed to quantify cutaneous
vessel numbers and sizes. Three different fields per section
were examined, and the number of vessels per mm2, average
vessel size, and the relative area occupied by blood vessels
were determined within 200mm from the epidermal–dermal
junction. Vascular densities were found to be significantly
increased on day 2 (52.6% increase) and on day 3 (50.5%
increase) after UV irradiation compared with nonirradiated
skin (Figure 4c). In addition, average vessel size was
significantly increased on day 1 (45.3% increase), day 2
(57.2% increase), and day 3 (90.2% increase) post-UV
(Figure 4d). Consequently, the cutaneous area covered by
blood vessels located within 200 mm from epidermal–dermal
junction gradually increased from 1.5% in normal skin to
4.3% in UV-irradiated skin on day 3 (Figure 4e). These
changes in neovascularization were accompanied by in-
creased endothelial cell proliferation (data not shown), and
were prominent in the papillary dermis, which immediately
underlies the epidermis.
VEGF is upregulated by a single exposure to UV in human skin
epidermis
The effects of acute UV irradiation on epidermal VEGF
expression in sun-protected buttock skin were examined by
immunohistochemistry, Western blotting, and semiquanti-
tative RT-PCR. Whereas VEGF expression was low in
nonirradiated control skin, it was strongly expressed in the
granular layer day 1 post-UV (2 MED) irradiation (n¼ 3). On
days 2 and 3 post-UV, VEGF expression was distributed
throughout the epidermis (Figure 5a). Western blot analyses
of epidermis showed that VEGF expressions were signifi-
cantly increased on days 2 and 3 post-UV (n¼ 5, Figure 5b).
As shown in Figure 5c, VEGF mRNA was also overexpressed
on day 1 post-UV versus nonirradiated skin (n¼ 5). To
investigate the involvement of the ERK pathway, human
buttock skin was irradiated with 2 MED of UV and skin
biopsies were obtained from each subject at 2, 4, and 8 h,
and on days 1, and 2 post-UV. A significant increase in ERK
phosphorylation was observed at 4 and 8 hours post-UV and
this returned to its basal level at 2-day post-UV (n¼4, Figure
5d). UV exposure did not alter total ERK levels at these times,
and like HaCaT cells, the epidermis expressed considerably
more ERK2 than ERK1.
tRA inhibits UV-induced angiogenesis and VEGF upregulation in
human skin in vivo
We investigated whether pretreating human skin with tRA
could inhibit UV-induced cutaneous angiogenesis. Human
buttock skin (n¼ 4) was treated with vehicle and tRA
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Figure 3. tRA inhibited the induction of VEGF and ERK1/2 protein by UV in
HaCaT cells. Serum-starved cells were treated for 24 hours with tRA (109 M)
and then irradiated with UV (50 mJ/cm2). (a) Supernatants were analyzed
using a VEGF-specific ELISA at 6 hours post-UV. Data represent the
means7SEM of three independent experiments. *Po0.05 versus. vehicle-
pretreated nonirradiated cells, and wPo0.05 versus vehicle-pretreated cells in
each condition (Mann–Whitney U-test). (b) Cell lysates were analyzed using
Western blotting with anti-phospho ERK1/2 and ERK1/2 antibodies at 2 hours
post-UV. Similar results were obtained for three independent experiments.
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(0.025%) for 48 hours before UV irradiation (2 MED) under
occlusion. Skin samples were obtained at 48 hours after UV
irradiation and dermal vascularization was analyzed by
immunohistochemistry of CD31 (Figure 6a). tRA applied for
4 days to normal skin tended to increase the vascularity of the
dermis. Topical application of tRA before UV irradiation
significantly inhibited UV-induced angiogenesis as deter-
mined by vessel density (Figure 6c, 86.8% inhibition) and by
vessel area (Figure 6d, 64.6% inhibition), as compared with
skin pretreated with vehicle and exposed to UV. However,
tRA pretreatment did not affect UV-induced vessel size
increases (Figure 6b).
We next examined the effects of tRA on UV-induced VEGF
protein and mRNA expression, and ERK1/2 phosphorylation.
Human buttock skin was pretreated with vehicle and tRA
(0.025%) for 48 hours before UV irradiation (2 MED) under
occlusion, and skin samples were obtained 48 hours post-UV.
Immunohistology revealed that UV induced VEGF protein
throughout the epidermis and that tRA pretreatment substan-
tially inhibited UV-induced VEGF expression versus vehicle-
treated, UV-irradiated skin (n¼ 4, Figure 7a). Epidermis
thickness increases after UV irradiation and slightly inhibited
by tRA pretreatment. Moreover, the pretreatment of human
skin with tRA blocked UV-induced mRNA overexpression of
VEGF (n¼3, Figure 7b). Owing to maximal ERK activation
was observed 4 or 8 hours post-UV (Figure 5d), skin samples
were obtained at 8 hours post-UV and ERK phosphorylation
levels in epidermis were analyzed (n¼3, Figure 7c). Topical
pretreatment with tRA was found to significantly inhibit UV-
induced ERK1/2 activation versus vehicle-treated, UV-irra-
diated skin. These results indicate that topical treatment with
tRA can prevent acute UV response by inhibiting UV-induced
ERK1/2 activation, VEGF upregulation, and angiogenesis.
DISCUSSION
Angiogenesis has remained a major focus of cancer research
for the past two decades. However, the vascular changes are
also the clinical characteristics of noncancerous skin diseases
like rosacea and psoriasis (Bhushan et al., 2002). A recent
animal study suggested that skin angiogenesis plays a critical
role in photoaging, and that the inhibition of angiogenesis
diminishes UVB-induced wrinkle formation (Yano et al.,
2002). Although neovascularization is a typical reaction of
UV-associated skin diseases, the mechanism underlying
human skin angiogenesis remains unclear.
The level of VEGF, the major angiogenic factor, is
important parameter in maintaining balanced skin angiogen-
esis. It has been identified as a major keratinocyte-derived
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Figure 4. Acute UV exposure induced epidermal hyperplasia and angiogenesis in human skin. Sun-protected buttock skin was exposed to a single dose of
UV (2 MED) and samples were obtained by punch biopsy at 1, 2, and 3 days post-UV. (a) Haematoxylin and eosin staining and (b) immunohistochemical
staining for CD31 were performed on skin sections (see Materials and Methods, n¼ 3). Bar¼100 mm. (c) Vessel density, (d) vessel size, and (e) vessel area within
200mm from the epidermal–dermal junction were analyzed using a computer-assisted morphometric analysis program. Three different fields per section were
examined, and the number of vessels per mm2, the average vessel size, and the relative area occupied by blood vessels were determined in the papillary dermis.
Data are presented as means7SEM for three subjects. *Po0.05 versus nonirradiated normal skin (Wilcoxon Signed-Rank test).
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vessel-specific growth factor (Detmar et al., 1995), and the
expression has been reported to be upregulated in the
hyperplastic epidermis of psoriasis (Detmar et al., 1994), in
keloids (Gira et al., 2004), in basal cell carcinoma (Oh et al.,
2003), squamous cell carcinoma (Bowden et al., 2002),
melanoma (Gorski et al., 2003), and in chronic wounds
(Lauer et al., 2000). Recently, efforts have being made to
reduce VEGF levels for antiangiogenic and antitumor
therapy. Thus, studies on the regulation of VEGF in skin
provide a basic understanding that can be used for the
Vessels/mm2 Vessel area (%)Vessel size (m2)
UV (−)
VEH
VEH
tRA
tRA
VEH
tRA
VEH
tRA
0
50
100
150
0 0
0.5
1
1.5
2
3
2.5
50
100
150250
200
UV (+)
UV (−) UV (+) UV (−) UV (+) UV (−) UV (+)
VEH tRA
a
b c d
*
*
*

  
Figure 6. UV-induced dermal angiogenesis was inhibited by tRA in human skin in vivo. Human skin was pretreated with vehicle and 0.025% tRA for 48 hours
before UV irradiation (2 MED). Skin samples were obtained 48 hours after UV exposure. (a) Immunohistological staining of CD31, (b) vessel size, (c) vessel
density, and (d) blood vessel area within 200mm from the epidermal–dermal junction were analyzed. Computer-assisted image analysis of CD31 stained
sections was performed in three different fields per section. Data are presented as means7SEM for four subjects. *Po0.05 versus vehicle-pretreated
nonirradiated cells, and wPo0.05 versus vehicle-pretreated cells in each condition (Wilcoxon Signed-Rank test). Bar¼ 100mm.
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Figure 5. Acute UV exposure induced VEGF overexpression and ERK1/2 activation in human skin epidermis. Sun-protected buttock skin was exposed
to a single dose of UV (2 MED). Samples were obtained by punch biopsy at the indicated times post-UV. (a) Immunostaining for VEGF was performed on
frozen sections (n¼3). Bar¼ 100mm. (b) Protein extracts from epidermis were analyzed by Western blotting using antibody for VEGF (n¼ 5). Epidermis was
separated from dermis with a forceps after incubating skin samples at 581C for 2 minutes in PBS. (c) Semiquantitative RT-PCR showed changes in VEGF
mRNA expressions in the epidermis (n¼5). The products of VEGF were of 516, 648, and 730 bp, and those of GAPDH were 565 bp, respectively. (d) The
time-dependent effect of UV on ERK1/2 activation was investigated in epidermis (n¼ 4). The results from all subjects were analyzed by densitometry
(normalization by actin or GAPDH) in the lower panels and results are presented as means7SEM for all subjects. *Po0.05 versus nonirradiated normal
skin (Wilcoxon Signed-Rank test).
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development of treatments for angiogenesis-associated skin
diseases.
In this study, we found that UV induces VEGF over-
expression in HaCaT keratinocytes and in the epidermis of
human skin. According to recent reports, the PI3K–Akt
pathway and the Ras-p42/p44 mitogen-activated protein
kinase (ERK1/2) signaling pathway play important regulatory
roles in angiogenesis (Berra et al., 2000; Segrelles et al.,
2004). Therefore, we investigated whether or not ERK1/2 and
Akt pathways are involved in UV-induced VEGF production
in keratinocytes. Our results show that UV-induced VEGF
overexpression was suppressed by U0126, a specific MEK
inhibitor, but not by wortmannin, a specific PI3K inhibitor,
which suggests that the MEK–ERK1/2 pathway is involved in
UV-stimulated VEGF upregulation in keratinocytes. In addi-
tion, tRA remarkably inhibited the UV-induced ERK1/2
activation and VEGF overexpression in keratinocytes.
It has been reported that UV can induce VEGF upregula-
tion in immortalized HaCaT cells developed from human
adult skin keratinocytes (Fusenig and Boukamp, 1998). It has
been demonstrated that the first induction of VEGF by UVB is
regulated in a coordinated fashion by the activation of
epidermal growth factor receptor and subsequent delayed
release of TGF-a (Blaudschun et al., 2000). It was also
reported that several stimulators induced VEGF upregulation
via mitogen-activated protein kinase signal transduction
pathways in keratinocytes. Recently, treatment of HaCaT
keratinocytes with insulin-like growth factor-II (IGF-II) was
reported to probably activate a single mitogen-activated
protein kinase pathway, that is, an ERK pathway, but not a
p38 or JNK pathway, and that this increasesd VEGF
expression (Kwon et al., 2004). Moreover, it was *demon-
strated that IGF-II induces VEGF gene expression via tyrosine
kinase-Src-ERK1/2 and PI3K pathways in HaCaT keratino-
cytes (Kim and Kim, 2005). In addition, VEGF secretion was
found to be regulated by tyrosine kinase-Src-ERK1/2, but this
secretion was independent of PI3K. Another stimulator,
hepatocyte growth factor/scatter factor, may functions as a
potent inducer of VEGF expression in keratinocytes (Gille
et al., 1998). Hepatocyte growth factor/scatter factor-induced
specificity protein 1 phosphorylation was suggested to acti-
vate VEGF promoter activity, which requires contributions by
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distinct signaling molecules, such as PI3K, ERK1/2, and PKC-
z (Reisinger et al., 2003). The results of the present study
show that UV-induced VEGF upregulation occurs via
MEK–ERK1/2 activation and not via PI3K-Akt activation in
human keratinocytes, and indicate that signal transduction
pathways associated with VEGF regulation depend on
specific stimulations in keratinocytes.
It is well known that retinoids regulate cell differentiation,
proliferation and apoptosis. In addition, they have been
shown to inhibit angiogenesis in vitro and in vivo experi-
ments (Liaudet-Coopman et al., 1997; Pal et al., 2000). Such
antiangiogenic effects of retinoids may be the result of
alterations in the activities of endothelial cells, for example,
the inhibition of endothelial cell migration, and in the
production of factors that stimulate or inhibit vessel growth.
In this study, we observed the inhibition of basal VEGF
expression by tRA in HaCaT keratinocytes. This inhibitory
effect is consistent with other reports that demonstrated that
RA inhibits spontaneous VEGF production in primary
cultured human normal keratinocytes (Weninger et al.,
1998; Lachgar et al., 1999). tRA has been reported to
stimulate or suppress the activation of mitogen-activated
protein kinase signaling pathways in different cell models
(Alsayed et al., 2001; Kunisada et al., 2005). Our results show
that tRA inhibits UV-induced VEGF expression via ERK1/2
downregulation in keratinocytes. However, in contrast to our
results concerning the inhibitory effect of tRA on VEGF
expression, it was suggested that RA stimulates the release of
VEGF via ERK1/2 activation in aortic smooth muscle cells
(Tanabe et al., 2004). The reasons of this discrepancy and
how RA affects ERK activation still remain to be investigated.
Further studies are needed to understand the molecular
mechanism of the inhibitory effects of tRA on UV-induced
ERK1/2 activation.
Topical retinoids are widely used to treat psoriasis and
rosacea, which suggests that VEGF has a pathogenic role
(Rolewski, 2003). Topical retinoid therapy is also used to
reverse some of the effects of photoaging (Stratigos and
Katsambas, 2005). The long-term application of tRA drama-
tically changes the skin architecture; it increases epidermal
thickness, facilitates the depositions of extracellular matrix
proteins, and increases dermal vascularity. The short-term
application of tRA (for 4 days) to buttock skin in this study
also tended to increase dermal vascularity and epidermal
VEGF expression. These findings contradict the in vitro results
concerning the inhibition of basal VEGF expression by tRA in
keratinocytes. It is possible that the effects of tRA treatment in
keratinocytes in vitro differ from its effects when applied
topically to epidermis in human skin in vivo.
Our results show that (i) tRA inhibits basal VEGF
expression in keratinocytes in vitro, but induces VEGF
expression in human skin epidermis in vivo; (ii) tRA blocks
UV-induced VEGF expression both in vitro and in vivo; and
(iii) that this inhibitory effect of tRA depends on the inhibition
of ERK1/2 phosphorylation in signaling pathways. Thus, our
results indicate that tRA has an inhibitory effect on UV-
induced angiogenesis via the downregulation of VEGF
signaling. These findings demonstrate that tRA is a potent
inhibitor of the angiogenesis caused by UV exposure, and
that it might be a useful therapeutic agent against angiogen-
esis-associated photo-damages.
Despite recent advances in our understanding of angio-
genesis, many questions remain unanswered. Further studies
are needed to characterize the relationship between skin
angiogenesis and the skin damage induced by UV. In
addition, we need to know whether RA can regulate other
angiogenic factors and signaling molecules that alter the
molecular balance for angiogenesis in human skin.
In conclusion, our study demonstrates for the first time that
acute exposure to UV radiation triggers angiogenesis via
VEGF induction and MEK–ERK1/2 activation, and that tRA
inhibits UV-induced ERK1/2 activation, VEGF upregulation,
and angiogenesis in human skin (Figure 8). Thus, a strategy
based on VEGF inhibition after UV exposure may prevent or
arrest the evolution of skin damages associated with UV,
which are characterized by increased vascular permeability
and angiogenesis. An understanding of the cascade of
molecular signals in UV-induced signaling pathways may
provide us with new insights and therapeutic target mole-
cules that allow the prevention of angiogenesis-associated
skin photo-damages.
MATERIALS AND METHODS
Reagents and antibodies
Cell culture medium, DMEM, and fetal bovine serum were
purchased from Gibco BRL (Grand Island, NY), and U0126,
wortmannin and tRA (tretinoin) from Sigma-Aldrich, Inc. (St Louis,
MO). For RT-PCR, VEGF, and GAPDH primer sets were synthesized
by Bioneer Co. (DaeJeon, Korea). For immunohistochemistry and
Western blotting, anti-human CD31 antibody was purchased from
PharMingen (San Diego, CA); anti-human VEGF antibody from Santa
Cruz Biotechnology (Santa Cruz, CA); phospho-specific ERK and
total ERK antibodies from Cell Signaling Technology (Beverly, MA);
and anti-mouse IgG and anti-rabbit IgG conjugated peroxidase from
Amersham Pharmacia Biotechnology (Braunschweig, Germany). For
ELISA, anti-human VEGF antibody, biotinylated anti-human VEGF
UV
MEK/ERK
VEGF tRA
tRA
tRA
Human skin epidermis
(keratinocytes)
Dermal angiogenesis
Figure 8. Schematic representation of UV-induced angiogenesis in human
skin. UV upregulates keratinocyte-derived VEGF and promotes dermal
angiogenesis through the MEK–ERK1/2 pathway in human skin. tRA
effectively inhibited UV-induced ERK1/2 activation, consecutive VEGF
overexpression, and dermal angiogenesis in human skin in vivo.
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antibody, and recombinant VEGF were obtained from R&D Systems
(Minneapolis, MN).
Cell culture and UV exposure
The human epidermal cell line, HaCaT, was cultured in DMEM
supplemented with 10% fetal bovine serum, penicillin (400 U/ml),
streptomycin (50 mg/ml), and glutamine (2 mM), and grown on plastic
tissue culture dishes in a humidified 5% CO2 atmosphere at 371C. A
Waldmann broad-band UVB (Waldmann, Villingen-Schwenningen,
Germany) phototherapy device equipped with F85/100W/UV21
fluorescent sunlamps with an emission spectrum between 285 and
350 nm (peaking 313 nm) was used as the UV source. A Kodacel
filter (TA401/407, Kodak, Rochester, NY) was mounted 5 cm in front
of the UV lamps to remove wavelengths of less than 290 nm (UVC).
UV intensity was measured using a Waldmann UV meter (Model
No. 585100). In order to avoid interference due to the cytotoxic
effect of UV, MTT assays were performed to determine the optimal
noncytotoxic dose (40–100 mJ/cm2). Subconfluent monolayer cul-
tures of serum-starved HaCaT cells (2 105 cells/ml) were rinsed
with phosphate-buffered saline (PBS) and thereafter irradiated under
a thin layer of PBS at a UV dose of 50 mJ/cm2. Sham-irradiated
control cells were handled in an identical manner, but were not
exposed to UV. After irradiation, media were replenished with fresh
DMEM medium without fetal bovine serum, and cells were cultured
for various times. In experiments involving treatment with inhibitors,
cells were pretreated with 20 mM U0126 (a specific MEK inhibitor) or
50 nM wortmannin (a specific PI3K inhibitor) for 30 minutes before
UV irradiation. In experiments involving tRA, cells were preincu-
bated with 109 M tRA for 24 hours before UV irradiation. All
reagents were dissolved in DMSO, and cells were treated with the
same amounts of DMSO in medium before UV irradiation.
Measurement of VEGF secretion
After UV irradiation, cell-free supernatants were collected and stored
at 701C until required for cytokine assay. Secreted VEGF levels in
the culture media of HaCaT cells were determined by sandwich
ELISA, according to the manufacture’s protocol (R&D systems).
Absorption of avidin-horseradish peroxidase color reaction was
measured at 405 nm and VEGF concentrations were determined
using a standard graph prepared using serial dilutions of human
recombinant human VEGF as a standard.
Human skin samples
Eighteen Korean volunteers (17 men and 1 woman, mean age
28.071.3 year, age range 20–36 year) without current or prior skin
disease were enrolled in the study. For UV exposure, we used the
device described above for in vitro study. The MED for each subject
was determined 24 hours after irradiation. Usually, the MED
measured for filtered UV was around 70–90 mJ/cm2. The phototypes
of the volunteers include types III, IV, and V. Irradiated (2 MED of
UV) and nonirradiated buttock skin samples were obtained from
each subject by punch biopsy at the indicated time points after UV
irradiation. The samples were placed immediately into a cryomatrix
(Shandon, Pittsburgh, PA) for immunohistochemical staining and
into liquid nitrogen for Western blotting, and all samples were stored
at 701C until required. This study was conducted according to the
Declaration of Helsinki Principles. All procedures involving human
subjects were approved by the Institutional Review Board at the
Seoul National University Hospital, and all subjects provided written
informed consent.
tRA preparation and topical application
tRA was freshly emulsified in polyethyleneglycol 400 (PEG 400) and
maintained at 41C in dark tubes. The buttock skins of young subjects
were treated with 0.025% tRA and vehicle (62.5 ml/cm2) under
occlusion for 48 h, and then treated skins were irradiated with 2
MED of UV. Skin samples were obtained at 8 hours (for ERK analysis)
or 48 hours (for VEGF and vascularization analysis) post-UV from
each subject by punch biopsy.
Western blotting analysis
After irradiated and non-irradiated buttock skin samples had been
obtained from each subject by punch biopsy, epidermis and dermis
were separated using a forceps after incubating skin samples at 581C
for 2 minutes in PBS. Soluble protein was extracted from epidermis
and HaCaT cells using a lysis buffer containing 50 mM Tris-HCl (pH
7.4), 1% Triton X-100, 75 mM NaCl, 1 mM EDTA, 1 mM PMSF, 1 mM
DTT, and protease inhibitor cocktail (Sigma-Aldrich). The protein
concentrations of extracts were measured by BCA protein dye
reagent. VEGF levels were determined in protein extracts from
epidermis samples and HaCaT cells. Samples were loaded and
separated on 10% SDS-polyacrylamide gels, and proteins were
electrotransferred onto nitrocellulose membranes (Amersham Phar-
macia) at 41C. Membranes were then blocked with 5% nonfat dry
milk in PBS containing 0.1% Tween-20 (PBST) for 1 h, and after a
brief wash with PBST, membranes were probed with primary
antibody for 1 h, and washed three times with PBST. They were
then treated with horseradish peroxidase-conjugated secondary
antibody for 45 minutes and blots were detected using ECL detection
reagent (Amersham Biosciences, Piscataway, NJ). Proteins were
visualized by fluorography using Agfa X-ray film blue. Bands were
quantified using a densitometric program (Bio 1D; Vilber Lourmat,
Torcy Z.I., France).
Semiquantitative RT-PCR
Total RNA was extracted from tissues and cells using TRIZOL reagent
(Invitrogen Life Technologies, Carlsbad, CA), and 1 mg of total RNA
was converted to cDNA using reverse transcriptase at 371C for
1 hours (First Strand cDNA Synthesis Kit, Fermentas, Hanover, MD).
PCR reactions were performed using 0.5–2ml of cDNA and
prealiquoted ReddyMixTM PCR master mix (Abgene, Surrey, UK).
Optimal semiquantitative conditions were set to fall in the linear
PCR product range (data not shown). PCR consisted of 34
amplification cycles (941C, 30 seconds; 601C, 30 seconds; 721C,
1 min) for human VEGF using oligonucleotide primer sets. In
parallel, the GAPDH gene was amplified in each RNA sample as
an internal control. The VEGF primers used were 50-CCA TGA ACT
TTC TGC TGT CTT-30 (forward) and 50-TCG ATC GTT CTG TAT
CAG TCT-30 (reverse), and the GAPDH primers used were 50-ATT
GTT GCC ATC AAT GAC CC-30 (forward) and 50-AGT AGA GGC
AGG GAT GAT GT-30 (reverse). The primer sets used yielded PCR
products of 516, 648 and 730 bp for VEGF121, VEGF165, and
VEGF189, respectively. PCR products were electrophoresed on 1.8%
agarose gels and visualized with ethidium bromide. Signal strengths
were quantified using a densitometric program (Bio 1D; Vilber
Lourmat, Torcy Z.I., France).
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Immunohistochemistry
Frozen human skin tissues were examined for VEGF and CD31
expression as described previously (Chung et al., 2002). Briefly,
snap-frozen tissues were placed immediately into a cryomatrix
(Shandon, Pittsburgh, PA), stored at 701C, sectioned at 4 mm,
mounted onto silane-coated slides (Dako, Glostrup, Denmark), and
acetone fixed at 201C for 15 min. The frozen sections were then
rehydrated in DW and endogenous peroxidase activity was
quenched using 3% hydrogen peroxide for 10 min. The sections
were then blocked with blocking solution (Zymed, San Francisco,
CA) for 30 min, and washed and incubated with primary antibodies
in a humidified chamber at 41C for 18 h. After washing in PBS, they
were incubated with biotinylated secondary antibody for 30 min,
followed by horseradish-streptoavidin conjugate for 15 min. After a
further washing in PBS, color was developed using AEC (3-amino-9-
ethylcarbazole; Zymed) for 5–10 min. The sections were then
washed in running tap water for 5 min, and cell nuclei were
counterstained with Mayer’s hematoxylin (Dako). The cutaneous
blood vessel numbers and diameters were captured and analyzed
using an image analysis program (Vedio Test-Master Morphology,
Image and Microscope Technology, Korea). Vessel numbers per
mm2, average vessel sizes, and the relative areas occupied by vessels
were determined in dermis. Three different  200 fields within
200mm from the epidermal–dermal junction were examined in the
dermis of each section.
Statistics
Results are expressed as means7SEM of independent experiments,
and all experiments were repeated at least four times. The
significance of differences between independent two groups was
analyzed using the Mann–Whitney U-test and that of differences
between dependent two groups was analyzed using the Wilcoxon
Signed-Rank test. For all tests, a P-value of o0.05 was considered
statistically significant. All data were analyzed using SPSS 11.0 for
Windows (SPSS Inc., Chicago, IL).
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